In addition, as a major component of intracellular anti-inflammatory proteins, NLRC3 can negatively regulate inflammatory signaling pathways, reduce the release of inhibitory immune regulatory mediators, and increase the secretion of chemokines related immune cell infiltration into the TME, thereby causing the increase of anti-tumor lymphocytes in the body tissues (27). This evidence concerns the gene NLRC3 and neoplasm.